Heading to ASRM 2023!

ASRM 2023 is the Annual Meeting the American Society for Reproductive Medicine organized. The purpose is to champion excellence in research and education in reproductive medicine, drawing together professionals, businesses, clinicians, patients, and policymakers from all corners of the world.

This year, we're venturing to the lively city of New Orleans from 14-18th October and we're eager to discuss our innovative solutions and introduce them to the community there. We are actively seeking strategic partnerships and alliances, and we'd be delighted to engage with you during the event.

Ula Sankowska & Piotr Wygocki, PhD

co-CEOs MIM Fertility

?? Meet with Ula and Piotr: calendar

Newest updates and achievements from our work?

• FOLLISCAN, our AI-powered software platform for 10-second ovarian ultrasound monitoring,? received Best Innovation in Fertility Care Awards 2023 by the European Fertility Society
• We are in the process of validating Folliscan Plus, which contains the 'trigger date prediction' component
• MIM Fertility conducts an international Prospective Study with IVF clinics from Poland and Mexico. The aim of the study is the prospective validation of the EMBRYOAID software for the automatic evaluation of embryos on the 5th day after fertilization during the in vitro procedure. The results will be analyzed and published in q1 2024.?
• Our AI software platform for embryo assessment is undergoing integration with ESCO and GERI incubators
• Dr. Ester Polak de Fried, Chief Scientific Director of ALMER and Dr. Antonio Vidal Pascual Rodriguez, Director of the Fertility Laboratory at Instituto Vida Guadalajara joined the Scientific Advisory Board of MIM Fertility
• MIM Solutions (MIM Fertility belongs to the MIM Solutions Group) was invited by the EU President Ursula von der Leyen to join the Business Advisory Group for Global Gateway Fund

Want to know more? Follow us on LinkedIn to learn about each of them in the upcoming days!

Who are we?

At MIM Fertility (20 Machine Learning experts on board) we develop cutting-edge AI-driven software platforms to support fertility professionals in their decision-making process. . Our two flagship AI technologies FOLLISCAN and EMBRYOAID enhance the standard of fertility care by automating ovarian ultrasound monitoring and helping embryologists in embryo assessment.?

In the sphere of fertility care, we are striving for excellence. We are seeking partners who share our dedication to elevating IVF success rates and standardizing care for those battling infertility. Partner with us, we can shape the future of reproductive medicine together. Your expertise, combined with AI excellence, can make dreams for countless couples.

?? Want to be a part of it? Meet us at ASRM 2023 in New Orleans!

?? Meet with Ula and Piotr: calendar